HRSA Denounces J&J’s Proposed Rebate Model

Today, the Health Resources and Services Administration (HRSA) issued a letter to Johnson and Johnson Health Care System Inc. (J&J) calling for the manufacturer to “cease implementation of its rebate…

AstraZeneca Will Require Submission of Claims Data to 340B ESP™ for Covered Entities to Designate Single Contract Pharmacy

Beginning October 1, 2024, AstraZeneca will require all covered entities to submit 340B claims utilization data to ESP™ as a pre-requisite for designating a single contract pharmacy.  This announcement, released…

EMD Serono Updates Contract Pharmacy to Include Grantees, With Limited Exceptions

EMD Serono (EMDS) announced that it will apply its contract pharmacy restrictions to all covered entities beginning October 1, 2024.  EMDS is allowing an exception to Ryan White Clinics for purchases…